A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...

Marker Therapeutics (NASDAQ:MRKR – Get Free Report) is expected to announce its earnings results before the market opens on ...

There are so many false promises online when it comes to losing weight. Here are my top weight loss technologies that ...

Histotripsy, a non-invasive procedure for liver cancer treatment, is now available in Metairie, offering hope to patients in ...

Learn how ultrafine bubble showers can improve eczema symptoms by reducing inflammation and enhancing skin barrier proteins.

RESTEM, LLC v. JADI CELL, LLC - Before Moore, Schall, and Taranto. Appeal from the Patent Trial and Appeal Board. Inherency in ...

Intermittent fasting has gained widespread popularity for its benefits in weight management and metabolic health. However, its impact on brain chemistry is ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

This A-List features two lists of sequencing instrument providers: eight for NGS instruments and three for Sanger ...

Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.

A team of researchers has identified a mechanism that regulates the production of two different proteins from the same gene.

The discovery could pave the way for a groundbreaking RNA-based multi-cancer treatment. Alternative RNA splicing functions ...